Literature DB >> 22686867

Kraepelin and Bleuler had it right: people with schizophrenia have deficits sustaining attention over time.

Britta Hahn1, Benjamin M Robinson, Samuel T Kaiser, Tatyana M Matveeva, Alexander N Harvey, Steven J Luck, James M Gold.   

Abstract

An inability to sustain attention was noted in the original clinical descriptions of schizophrenia, but the vast majority of experimental studies have failed to report a performance decrement over time, calling this observation into question. To test for such deficits when task conditions conform to basic science taxonomy for the validity of sustained attention tasks, a dynamic stimulus array was presented in which targets, differing subtly from standard stimuli, were presented infrequently and unpredictably. Both people with schizophrenia (PSZ, n=40) and healthy control subjects (HCS, n=29) displayed a reduction in hit rate and an increase in reaction time (RT) from the first to the second 5-min period. Thereafter, the hit rate of HCS recovered and remained stable, while that of PSZ continued to decline. When performance at task onset was equated between groups, the decrement over time in PSZ remained of the same robust magnitude. Thus, when the nature of the task challenges sustaining attention over time, PSZ display a clear deficit in this ability. PsycINFO Database Record (c) 2012 APA, all rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22686867      PMCID: PMC3746344          DOI: 10.1037/a0028492

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  36 in total

1.  More severe sustained attention deficits in nonpsychotic siblings of multiplex schizophrenia families than in those of simplex ones.

Authors:  Hui-Chun Tsuang; Sheng-Hsiang Lin; Shi K Liu; Ming-Hsien Hsieh; Tzung J Hwang; Chih-Min Liu; Hai-Gwo Hwu; Wei J Chen
Journal:  Schizophr Res       Date:  2006-06-05       Impact factor: 4.939

2.  Reaction time of the Continuous Performance Test is an endophenotypic marker for schizophrenia: a study of first-episode neuroleptic-naive schizophrenia, their non-psychotic first-degree relatives and healthy population controls.

Authors:  Qiang Wang; Raymond Chan; Jinhua Sun; Jing Yao; Wei Deng; Xueli Sun; Xiehe Liu; Pak C Sham; Xiaohong Ma; Huaqing Meng; Robin M Murray; David A Collier; Tao Li
Journal:  Schizophr Res       Date:  2006-10-19       Impact factor: 4.939

3.  Sustained and selective attention as measures of genetic liability to schizophrenia.

Authors:  L A Jones; A G Cardno; R D Sanders; M J Owen; J Williams
Journal:  Schizophr Res       Date:  2001-03-30       Impact factor: 4.939

4.  Attention dysfunction in chronic schizophrenia.

Authors:  M H Orzack; C Kornetsky
Journal:  Arch Gen Psychiatry       Date:  1966-03

5.  Attentional impairments in deficit and nondeficit forms of schizophrenia.

Authors:  R W Buchanan; M E Strauss; A Breier; B Kirkpatrick; W T Carpenter
Journal:  Am J Psychiatry       Date:  1997-03       Impact factor: 18.112

6.  Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients.

Authors:  W J Chen; S K Liu; C J Chang; Y J Lien; Y H Chang; H G Hwu
Journal:  Am J Psychiatry       Date:  1998-09       Impact factor: 18.112

7.  Re-examining sustained attention deficits as vulnerability indicators for schizophrenia: stability in the long term course.

Authors:  Shi K Liu; Ming-Hsien Hsieh; Tzung J Hwang; Hai-Gwo Hwu; Shih-Cheng Liao; Sheng-Hsiang Lin; Wei J Chen
Journal:  J Psychiatr Res       Date:  2006-08-10       Impact factor: 4.791

Review 8.  Information-processing abnormalities as neuropsychological vulnerability indicators for schizophrenia.

Authors:  K H Nuechterlein; M E Dawson; M F Green
Journal:  Acta Psychiatr Scand Suppl       Date:  1994

9.  Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs.

Authors:  Nancy C Andreasen; Marcus Pressler; Peg Nopoulos; Del Miller; Beng-Choon Ho
Journal:  Biol Psychiatry       Date:  2009-11-07       Impact factor: 13.382

10.  Visual sustained attention: image degradation produces rapid sensitivity decrement over time.

Authors:  K H Nuechterlein; R Parasuraman; Q Jiang
Journal:  Science       Date:  1983-04-15       Impact factor: 47.728

View more
  11 in total

1.  Enhancing and Promoting Recovery In Attentionally Impaired People Diagnosed With Schizophrenia: Results From A Randomized Controlled Trial Of Attention Shaping In A Partial Hospital Program.

Authors:  Steven M Silverstein; Matthew W Roché; Zaynab Khan; Sarah J Carson; Igor Malinovsky; William A Newbill; Anthony A Menditto; Sandra M Wilkniss
Journal:  Am J Psychiatr Rehabil       Date:  2014

Review 2.  Targeting neuronal dysfunction in schizophrenia with nicotine: Evidence from neurophysiology to neuroimaging.

Authors:  Jason Smucny; Jason R Tregellas
Journal:  J Psychopharmacol       Date:  2017-04-26       Impact factor: 4.153

3.  Relationships between divided attention and working memory impairment in people with schizophrenia.

Authors:  Bradley E Gray; Britta Hahn; Benjamin Robinson; Alex Harvey; Carly J Leonard; Steven J Luck; James M Gold
Journal:  Schizophr Bull       Date:  2014-04-19       Impact factor: 9.306

Review 4.  Sustained attention in psychosis: Neuroimaging findings.

Authors:  Gianna Sepede; Maria Chiara Spano; Marco Lorusso; Domenico De Berardis; Rosa Maria Salerno; Massimo Di Giannantonio; Francesco Gambi
Journal:  World J Radiol       Date:  2014-06-28

5.  Participants with schizophrenia retain the information necessary for informed consent during clinical trials.

Authors:  Bernard A Fischer; Robert P McMahon; Walter A Meyer; Daniel J Slack; Paul S Appelbaum; William T Carpenter
Journal:  J Clin Psychiatry       Date:  2013-06       Impact factor: 4.384

6.  Brief monocular deprivation as an assay of short-term visual sensory plasticity in schizophrenia - "the binocular effect".

Authors:  John J Foxe; Sherlyn Yeap; Victoria M Leavitt
Journal:  Front Psychiatry       Date:  2013-12-17       Impact factor: 4.157

7.  Impaired limbic cortico-striatal structure and sustained visual attention in a rodent model of schizophrenia.

Authors:  Samuel A Barnes; Stephen J Sawiak; Daniele Caprioli; Bianca Jupp; Guido Buonincontri; Adam C Mar; Michael K Harte; Paul C Fletcher; Trevor W Robbins; Jo C Neill; Jeffrey W Dalley
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

8.  Mice haploinsufficient for Map2k7, a gene involved in neurodevelopment and risk for schizophrenia, show impaired attention, a vigilance decrement deficit and unstable cognitive processing in an attentional task: impact of minocycline.

Authors:  R L Openshaw; D M Thomson; J M Penninger; J A Pratt; B J Morris
Journal:  Psychopharmacology (Berl)       Date:  2016-10-24       Impact factor: 4.530

9.  Fragile temporal prediction in patients with schizophrenia is related to minimal self disorders.

Authors:  Brice Martin; Nicolas Franck; Michel Cermolacce; Agnès Falco; Anabel Benair; Estelle Etienne; Sébastien Weibel; Jennifer T Coull; Anne Giersch
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

10.  Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice.

Authors:  J W Young; M A Geyer; A J Rissling; R F Sharp; L T Eyler; G L Asgaard; G A Light
Journal:  Transl Psychiatry       Date:  2013-11-12       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.